Longitudinal Assessment of Tumor-Infiltrating Lymphocytes in Primary Breast Cancer Following Neoadjuvant Radiation Therapy-Reference-Cited by-同舟云学术

Longitudinal Assessment of Tumor-Infiltrating Lymphocytes in Primary Breast Cancer Following Neoadjuvant Radiation Therapy

Published:2024-04 Issue: Volume: Page:
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Yoneyama Miki,Zormpas-Petridis Konstantinos,Robinson Ruth,Sobhani Faranak,Provenzano Elena,Steel Harriet,Lightowlers Sara,Towns Catherine,Castillo Simon P.,Anbalagan Selvakumar,Lund Tom,Wennerberg Erik,Melcher Alan,Coles Charlotte E.,Roxanis Ioannis,Yuan Yinyin,Somaiah Navita

Funder

NIHR BRC

Breast Cancer Now

Publisher

Elsevier BV

Reference38 articles.

1. Pembrolizumab for early triple-negative breast cancer;Schmid;N Engl J Med,2020

2. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group;El Bairi;NPJ Breast Cancer,2021

3. The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: Clinical utility in an era of checkpoint inhibition;Loi;Ann Oncol,2021

4. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: A pooled analysis of 3771 patients treated with neoadjuvant therapy;Denkert;Lancet Oncol,2018

5. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: A systematic review and meta-analysis;Gao;BMC Cancer,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer;Cancers;2024-08-20